Roche announced today the Global Access Program is expanding beyond HIV, to include Mycobacterium tuberculosis (MTB), Hepatitis B and C (HBV and HCV), and Human Papillomavirus (HPV) for low and middle income country programs where the disease burden is the highest.
Related topics
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
| A rapid TB test for people living with HIV | 0 | 456 | June 26, 2019 | |
| Time for $5: GeneXpert diagnostic tests | 0 | 765 | December 12, 2019 | |
| Point-of-Care CME on HIV, TB, and associated conditions | 0 | 618 | May 8, 2019 | |
| Two TB LAM briefs to support increased scale up | 1 | 511 | April 18, 2019 | |
| TAG Launches New Policy Brief: Advancing Access through Market Interventions: Lessons Learned from the GeneXpert Tuberculosis Test Buy-down | 0 | 602 | September 22, 2020 |